{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:28:37Z","timestamp":1794716917733,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["152001017"],"award-info":[{"award-number":["152001017"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4793-8","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T10:10:14Z","timestamp":1543227014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Satisfactory results of a psychometric analysis and calculation of minimal clinically important differences of the World Health Organization quality of life-BREF questionnaire in an observational cohort study with lung cancer and mesothelioma patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Mark","family":"de Mol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim G. J. V.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lodder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"den Oudsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"4793_CR1","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1200\/JCO.2008.17.7162","volume":"26","author":"Group NM-AC","year":"2008","unstructured":"Group NM-AC. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol. 2008;26:4617\u201325.","journal-title":"J Clin Oncol"},{"key":"4793_CR2","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/thx.2003.020164","volume":"59","author":"SG Spiro","year":"2004","unstructured":"Spiro SG, Rudd RM, Souhami RL, Brown J, Fairlamb DJ, Gower NH, Maslove L, Milroy R, Napp V, Parmar MK, et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax. 2004;59:828\u201336.","journal-title":"Thorax"},{"key":"4793_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2017_36","volume":"1022","author":"M Chabowski","year":"2017","unstructured":"Chabowski M, Polanski J, Mazur G, Janczak D, Rosinczuk J. Sociodemographic and clinical determinants of quality of life of patients with non-small cell lung Cancer. Adv Exp Med Biol. 2017;1022:1\u201310.","journal-title":"Adv Exp Med Biol"},{"key":"4793_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"4793_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","volume":"13","author":"SM Skevington","year":"2004","unstructured":"Skevington SM, Lotfy M, O\u2019Connell KA, Group W. The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13:299\u2013310.","journal-title":"Qual Life Res"},{"key":"4793_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1365-2354.2006.00654.x","volume":"15","author":"A Mohan","year":"2006","unstructured":"Mohan A, Mohan C, Bhutani M, Pathak AK, Pal H, Das C, Guleria R. Quality of life in newly diagnosed patients with lung cancer in a developing country: is it important? Eur J Cancer Care. 2006;15:293\u20138.","journal-title":"Eur J Cancer Care"},{"key":"4793_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1440-1843.2006.01038.x","volume":"12","author":"A Mohan","year":"2007","unstructured":"Mohan A, Mohan C, Pathak AK, Pandey RM, Guleria R. Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer. Respirology. 2007;12:240\u20137.","journal-title":"Respirology"},{"key":"4793_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1524-4733.2007.00310.x","volume":"11","author":"PC Trask","year":"2008","unstructured":"Trask PC, Tellefsen C, Espindle D, Getter C, Hsu MA. Psychometric validation of the cancer therapy satisfaction questionnaire. Value Health. 2008;11:669\u201379.","journal-title":"Value Health"},{"key":"4793_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34\u201342.","journal-title":"J Clin Epidemiol"},{"key":"4793_CR10","volume-title":"Applied statistics for the behavioral sciences","author":"DE Hinkle","year":"2003","unstructured":"Hinkle DE, Wiersma W, Jurs SG. Applied statistics for the behavioral sciences. 5th ed. Boston, Mass: Houghton Mifflin; 2003.","edition":"5"},{"key":"4793_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","year":"1998","unstructured":"Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL group. Psychol Med. 1998;28:551\u20138.","journal-title":"Psychol Med"},{"key":"4793_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1359105315603474","volume":"22","author":"CY Lin","year":"2017","unstructured":"Lin CY, Yang SC, Lai WW, Su WC, Wang JD. Rasch models suggested the satisfactory psychometric properties of the World Health Organization quality of life-brief among lung cancer patients. J Health Psychol. 2017;22:397\u2013408.","journal-title":"J Health Psychol"},{"key":"4793_CR13","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1093\/annonc\/mdq721","volume":"22","author":"T Luckett","year":"2011","unstructured":"Luckett T, King MT, Butow PN, Oguchi M, Rankin N, Price MA, Hackl NA, Heading G. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol. 2011;22:2179\u201390.","journal-title":"Ann Oncol"},{"key":"4793_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1037\/h0046016","volume":"56","author":"DT Campbell","year":"1959","unstructured":"Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull. 1959;56:81\u2013105.","journal-title":"Psychol Bull"},{"key":"4793_CR15","volume-title":"MAP-R for windows: multitrait.\/multi-item analysis program-revised User\u2019s guide","author":"JE Ware","year":"1997","unstructured":"Ware JE, Harris WJ, Gandek B, et al. MAP-R for windows: multitrait.\/multi-item analysis program-revised User\u2019s guide. Boston, MA: Health Assessment Lab; 1997."},{"key":"4793_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jclinepi.2008.03.006","volume":"62","author":"BL Den Oudsten","year":"2009","unstructured":"Den Oudsten BL, Van Heck GL, Van der Steeg AF, Roukema JA, De Vries J. The WHOQOL-100 has good psychometric properties in breast cancer patients. J Clin Epidemiol. 2009;62:195\u2013205.","journal-title":"J Clin Epidemiol"},{"key":"4793_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"LT Hu","year":"1999","unstructured":"Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6:1\u201355.","journal-title":"Struct Equ Model"},{"key":"4793_CR18","first-page":"582","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582\u201392.","journal-title":"Med Care"},{"key":"4793_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00005650-199905000-00006","volume":"37","author":"KW Wyrwich","year":"1999","unstructured":"Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999;37:469\u201378.","journal-title":"Med Care"},{"key":"4793_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0895-4356(99)00071-2","volume":"52","author":"KW Wyrwich","year":"1999","unstructured":"Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52:861\u201373.","journal-title":"J Clin Epidemiol"},{"key":"4793_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1014485627744","volume":"11","author":"KW Wyrwich","year":"2002","unstructured":"Wyrwich KW, Tierney WM, Wolinsky FD. Using the standard error of measurement to identify important changes on the asthma quality of life questionnaire. Qual Life Res. 2002;11:1\u20137.","journal-title":"Qual Life Res"},{"key":"4793_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1586\/erp.11.9","volume":"11","author":"MT King","year":"2011","unstructured":"King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res. 2011;11:171\u201384.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"4793_CR23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0895-4356(01)00407-3","volume":"54","author":"DE Beaton","year":"2001","unstructured":"Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. J Clin Epidemiol. 2001;54:1204\u201317.","journal-title":"J Clin Epidemiol"},{"key":"4793_CR24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/JTO.0b013e3182a46bcf","volume":"8","author":"A Rittmeyer","year":"2013","unstructured":"Rittmeyer A, Gorbunova V, Vikstrom A, Scherpereel A, Kim JH, Ahn MJ, Chella A, Chouaid C, Campbell AK, Barlesi F. Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089). J Thorac Oncol. 2013;8:1409\u201316.","journal-title":"J Thorac Oncol"},{"key":"4793_CR25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1097\/JTO.0b013e318267cf84","volume":"7","author":"C Gridelli","year":"2012","unstructured":"Gridelli C, de Marinis F, Pujol JL, Reck M, Ramlau R, Parente B, Pieters T, Middleton G, Corral J, Winfree K, et al. Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Thorac Oncol. 2012;7:1713\u201321.","journal-title":"J Thorac Oncol"},{"key":"4793_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/JTO.0000000000000277","volume":"10","author":"DR Spigel","year":"2015","unstructured":"Spigel DR, Patel JD, Reynolds CH, Garon EB, Hermann RC, Govindan R, Olsen MR, Winfree KB, Chen J, Liu J, et al. Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer. J Thorac Oncol. 2015;10:353\u20139.","journal-title":"J Thorac Oncol"},{"key":"4793_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/pon.3409","volume":"23","author":"AM Krebber","year":"2014","unstructured":"Krebber AM, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR, Becker A, Brug J, van Straten A, Cuijpers P, Verdonck-de Leeuw IM. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23:121\u201330.","journal-title":"Psychooncology"},{"key":"4793_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/jwh.2008.0959","volume":"18","author":"MG Bartoces","year":"2009","unstructured":"Bartoces MG, Severson RK, Rusin BA, Schwartz KL, Ruterbusch JJ, Neale AV. Quality of life and self-esteem of long-term survivors of invasive and noninvasive cervical cancer. J Women\u2019s Health (Larchmt). 2009;18:655\u201361.","journal-title":"J Women\u2019s Health (Larchmt)"},{"key":"4793_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jpsychores.2014.07.007","volume":"77","author":"L Ashley","year":"2014","unstructured":"Ashley L, Smith AB, Jones H, Velikova G, Wright P. Traditional and Rasch psychometric analyses of the quality of life in adult Cancer survivors (QLACS) questionnaire in shorter-term cancer survivors 15 months post-diagnosis. J Psychosom Res. 2014;77:322\u20139.","journal-title":"J Psychosom Res"},{"key":"4793_CR30","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jval.2013.05.004","volume":"16","author":"CL Shih","year":"2013","unstructured":"Shih CL, Chen CH, Sheu CF, Lang HC, Hsieh CL. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model. Value Health. 2013;16:848\u201354.","journal-title":"Value Health"},{"key":"4793_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/CMR.0b013e32835c7dd9","volume":"23","author":"JB Winstanley","year":"2013","unstructured":"Winstanley JB, Saw R, Boyle F, Thompson J. The FACT-melanoma quality-of-life instrument: comparison of a five-point and four-point response scale using the Rasch measurement model. Melanoma Res. 2013;23:61\u20139.","journal-title":"Melanoma Res"},{"key":"4793_CR32","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1016\/j.ejca.2006.08.016","volume":"42","author":"B Holzner","year":"2006","unstructured":"Holzner B, Bode RK, Hahn EA, Cella D, Kopp M, Sperner-Unterweger B, Kemmler G. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur J Cancer. 2006;42:3169\u201377.","journal-title":"Eur J Cancer"},{"key":"4793_CR33","first-page":"139","volume-title":"Structural Equation Modelling: Present and future","author":"A Boomsma","year":"2001","unstructured":"Boomsma A, Hoogland, J.J.: The robustness of LISREL modeling revisited. In Cudeck, R., Du Toit, S., S\u00f6rbom D. (Eds.), Structural Equation Modelling: Present and future. Chicago: Scientific Software. 2001. pp. 139\u2013168."},{"key":"4793_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1207\/s15327752jpa8501_02","volume":"85","author":"BM Byrne","year":"2005","unstructured":"Byrne BM. Factor analytic models: viewing the structure of an assessment instrument from three perspectives. J Pers Assess. 2005;85:17\u201332.","journal-title":"J Pers Assess"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4793-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T19:10:05Z","timestamp":1574709005000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4793-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4793"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4793-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"15 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all individual participants included in the study. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of the Erasmus University Medical Center in Rotterdam, the Netherlands (MEC-2012-232).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests except J. Aerts. J. Aerts has received personal fees as a member of the advisory board of Eli Lilly.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1173"}}